Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
Jubilant Ingrevia Ltd reported Revenues for Q3FY25 of ₹1,057.00 Crores up from ₹966.00 Crore year on year, a rise of 9.42%.
Total Expenses for Q3FY25 of ₹970.00 Crores up from ₹920.00 Crores year on year, a rise of 5.43%.
Consolidated Net Profit of ₹69.00 Crores up 76.92% from ₹39.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.36, up 80.17% from ₹2.42 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
